Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Biotechnology

Thermo Fisher invests in bioprocess capacity

by Michael McCoy
March 12, 2021 | A version of this story appeared in Volume 99, Issue 9

 

Thermo Fisher Scientific plans to spend more than $600 million this year and next to expand its bioprocessing capabilities for biotech industry customers. The firm will invest in single-use bioprocessor technology at six sites in the US, Europe, and Asia. It will expand chromatography resin capacity in Bedford, Massachusetts, and open a new facility in Chelmsford, Massachusetts. And it will expand capacity for cell culture media at three sites. Thermo Fisher says the moves will create more than 1,500 jobs.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.